DOCSLIB.ORG

Elabscience 16-17

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Elabscience 16-17 Elabscience - 2016-17 Catalog Description Pack Size Supplier Price (RS) E-EL-H0001 Human α1-AGP (Alpha-1-Acid Glycoprotein) ELISA Kit 96 T Elabscience 36990 E-EL-H0002 Human ACE (Angiotensin I Converting Enzyme) ELISA Kit 96 T Elabscience 36990 E-EL-H0003 Human ACVA (Activin A) ELISA Kit 96 T Elabscience 36990 E-EL-H0004 Human ADP/Acrp30 (Adiponectin) ELISA Kit 96 T Elabscience 36990 E-EL-H0005 Human AgRP (Agouti Related Protein) ELISA Kit 96 T Elabscience 36990 E-EL-H0006 Human ANG (Angiogenin) ELISA Kit 96 T Elabscience 36990 E-EL-H0007 Human ANG1 (Angiopoietin 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0008 Human ANG2 (Angiopoietin 2) ELISA Kit 96 T Elabscience 36990 E-EL-H0009 Human BAFF/CD257 (B-Cell Activating Factor) ELISA Kit 96 T Elabscience 36990 E-EL-H0010 Human BDNF (Brain Derived Neurotrophic Factor) ELISA Kit 96 T Elabscience 36990 E-EL-H0011 Human BMP-2 (Bone Morphogenetic Protein 2) ELISA Kit 96 T Elabscience 36990 E-EL-H0012 Human BMP-4 (Bone Morphogenetic Protein 4) ELISA Kit 96 T Elabscience 36990 E-EL-H0013 Human BMP-7 (Bone Morphogenetic Protein 7) ELISA Kit 96 T Elabscience 36990 E-EL-H0014 Human E-Cad (E-Cadherin) ELISA Kit 96 T Elabscience 36990 E-EL-H0015 Human CA9 (Carbonic Anhydrase IX) ELISA Kit 96 T Elabscience 36990 E-EL-H0016 Human CASP1 (Caspase 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0017 Human CASP3 (Caspase 3) ELISA Kit 96 T Elabscience 36990 E-EL-H0018 Human CTSB (Cathepsin B) ELISA Kit 96 T Elabscience 36990 E-EL-H0019 Human CTSV (Cathepsin V) ELISA Kit 96 T Elabscience 36990 E-EL-H0020 Human MCP-1 (Monocyte Chemotactic Protein 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0021 Human MIP-1α (Macrophage Inflammatory Protein 1 Alpha) ELISA Kit 96 T Elabscience 36990 E-EL-H0022 Human MIP-1β (Macrophage Inflammatory Protein 1 Beta) ELISA Kit 96 T Elabscience 36990 E-EL-H0023 Human RANTES (Regulated On Activation, Normal T-Cell Expressed and 96 T Elabscience 36990 Secreted) ELISA Kit E-EL-H0024 Human MCP-3 (Monocyte Chemotactic Protein 3) ELISA Kit 96 T Elabscience 36990 E-EL-H0025 Human ECF/CCL11 (Eosinophil Chemotactic Factor) ELISA Kit 96 T Elabscience 36990 E-EL-H0026 Human TARC (Thymus Activation Regulated Chemokine) ELISA Kit 96 T Elabscience 36990 E-EL-H0027 Human MIP-3α (Macrophage Inflammatory Protein 3 Alpha) ELISA Kit 96 T Elabscience 36990 E-EL-H0028 Human SLC (Secondary Lymphoid Tissue Chemokine) ELISA Kit 96 T Elabscience 36990 E-EL-H0029 Human MDC (Macrophage Derived Chemokine) ELISA Kit 96 T Elabscience 36990 E-EL-H0030 Human MPIF2 (Myeloid Progenitor Inhibitory Factor 2) ELISA Kit 96 T Elabscience 36990 E-EL-H0031 Human MIP4α (Macrophage Inflammatory Protein 4 Alpha) ELISA Kit 96 T Elabscience 36990 E-EL-H0032 Human CTACK (Cutaneous T-cell Attracting Chemokine) ELISA Kit 96 T Elabscience 36990 E-EL-H0033 Human sCD14 (Soluble Cluster of Differentiation14) ELISA Kit 96 T Elabscience 36990 E-EL-H0034 Human FcεRII/CD23 (Receptor II for the Fc Region of Immunoglobulin 96 T Elabscience 36990 E) ELISA Kit E-EL-H0035 Human sCD40L(Soluble Cluster of Differentiation 40 Ligand) ELISA Kit 96 T Elabscience 36990 E-EL-H0036 Human sCD163 (Soluable Cluster of Differentiation 163) ELISA Kit 96 T Elabscience 36990 E-EL-H0037 Human GP39 (Glycoprotein 39, Cartilage) ELISA Kit 96 T Elabscience 36990 1 Elabscience - 2016-17 Catalog Description Pack Size Supplier Price (RS) E-EL-H0038 Human CLU (Clusterin) ELISA Kit 96 T Elabscience 36990 E-EL-H0039 Human CNTF (Ciliary Neurotrophic Factor) ELISA Kit 96 T Elabscience 36990 E-EL-H0040 Human TF (Tissue Factor) ELISA Kit 96 T Elabscience 36990 E-EL-H0041 Human CFD (Complement Factor D) ELISA Kit 96 T Elabscience 36990 E-EL-H0042 Human CRN (Corin) ELISA Kit 96 T Elabscience 36990 E-EL-H0043 Human CRP (C-Reactive Protein) ELISA Kit 96 T Elabscience 36990 E-EL-H0044 Human CX3CL1 (Chemokine C-X3-C-Motif Ligand 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0045 Human GROα/CXCL1 (Growth Regulated Oncogene Alpha) ELISA Kit 96 T Elabscience 36990 E-EL-H0046 Human ENA-78 (Epithelial Neutrophil Activating Peptide 78) ELISA Kit 96 T Elabscience 36990 E-EL-H0047 Human GCP-2 (Granulocyte Chemotactic Protein 2) ELISA Kit 96 T Elabscience 36990 E-EL-H0048 Human IL-8 (Interleukin 8) ELISA Kit 96 T Elabscience 36990 E-EL-H0049 Human AAHA (Anti-Apolipoprotein Antibody) ELISA Kit 96 T Elabscience 36990 E-EL-H0050 Human IP-10/CXCL10 (Interferon Gamma Induced Protein 10kDa) 96 T Elabscience 36990 ELISA Kit E-EL-H0051 Human I-TAC (Interferon Inducible T-cell Alpha Chemoattractant) ELISA 96 T Elabscience 36990 Kit E-EL-H0052 Human SDF-1 (Stromal Cell Derived Factor 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0053 Human BLC (B-Lymphocyte Chemoattractant) ELISA Kit 96 T Elabscience 36990 E-EL-H0054 Human CXCL16 (Chemokine C-X-C-Motif Ligand 16) ELISA Kit 96 T Elabscience 36990 E-EL-H0055 Human Cys-C (Cystatin C) ELISA Kit 96 T Elabscience 36990 E-EL-H0056 Human Cyt-C (Cytochrome C) ELISA Kit 96 T Elabscience 36990 E-EL-H0057 Human DKK1 (Dickkopf Related Protein 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0058 Human DPP4 (Dipeptidyl Peptidase IV) ELISA Kit 96 T Elabscience 36990 E-EL-H0059 Human EGF (Epidermal Growth Factor) ELISA Kit 96 T Elabscience 36990 E-EL-H0060 Human EGFR (Epidermal Growth Factor Receptor) ELISA Kit 96 T Elabscience 36990 E-EL-H0061 Human EG-VEGF (Endocrine Gland Derived Vascular Endothelial 96 T Elabscience 36990 Growth Factor)ELISA Kit E-EL-H0062 Human ENG (Endoglin) ELISA Kit 96 T Elabscience 36990 E-EL-H0063 Human ES (Endostatin) ELISA Kit 96 T Elabscience 36990 E-EL-H0064 Human ET-1 (Endothelin 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0065 Human EPCR (Endothelial Protein C Receptor) ELISA Kit 96 T Elabscience 36990 E-EL-H0066 Human EPO (Erythropoietin) ELISA Kit 96 T Elabscience 36990 E-EL-H0067 Human FAS/CD95 (Factor Related Apoptosis) ELISA Kit 96 T Elabscience 36990 E-EL-H0068 Human FASL/TNFSF6 (Factor Related Apoptosis Ligand) ELISA Kit 96 T Elabscience 36990 E-EL-H0069 Human FABP1 (Fatty Acid Binding Protein 1, Liver) ELISA Kit 96 T Elabscience 36990 E-EL-H0070 Human αFP (Alpha-Fetoprotein) ELISA Kit 96 T Elabscience 36990 E-EL-H0071 Human AFGF/FGF1 (Acidic Fibroblast Growth Factor 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0072 Human AAP (Alanine Aminopeptidase) ELISA Kit 96 T Elabscience 36990 E-EL-H0073 Human FGF19 (Fibroblast Growth Factor 19) ELISA Kit 96 T Elabscience 36990 E-EL-H0074 Human FGF21 (Fibroblast Growth Factor 21) ELISA Kit 96 T Elabscience 36990 E-EL-H0075 Human Flt3L (FMS Like Tyrosine Kinase 3 Ligand) ELISA Kit 96 T Elabscience 36990 E-EL-H0076 Human FST (Follistatin) ELISA Kit 96 T Elabscience 36990 E-EL-H0077 Human Hepc (Hepcidin) ELISA Kit 96 T Elabscience 36990 E-EL-H0078 Human Gas6 (Growth Arrest Specific Protein 6) ELISA Kit 96 T Elabscience 36990 2 Elabscience - 2016-17 Catalog Description Pack Size Supplier Price (RS) E-EL-H0079 Human G-CSF (Granulocyte Colony Stimulating Factor 3) ELISA Kit 96 T Elabscience 36990 E-EL-H0080 Human GDF15 (Growth Differentiation Factor 15) ELISA Kit 96 T Elabscience 36990 E-EL-H0081 Human GM-CSF (Granulocyte Macrophage Colony Stimulating Factor) 96 T Elabscience 36990 ELISA Kit E-EL-H0082 Human sgp130 (soluble Glucoprotein 130) ELISA Kit 96 T Elabscience 36990 E-EL-H0084 Human HGF (Hepatocyte Growth Factor) ELISA Kit 96 T Elabscience 36990 E-EL-H0085 Human IFN-β(Interferon Beta)ELISA Kit 96 T Elabscience 36990 E-EL-H0086 Human IGF-1 (Insulin-Like Growth Factor 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0087 Human IGFBP-3 (Insulin Like Growth Factor Binding Protein 3) ELISA Kit 96 T Elabscience 36990 E-EL-H0088 Human IL-1α (Interleukin 1 Alpha) ELISA Kit 96 T Elabscience 36990 E-EL-H0089 Human IL-1ra/IL-1F3 (Interleukin 1 Receptor Antagonist) ELISA Kit 96 T Elabscience 36990 E-EL-H0090 Human IL-1R2 (Interleukin 1 Receptor Type II) ELISA Kit 96 T Elabscience 36990 E-EL-H0091 Human fPSA (Free Prostate Specific Antigen) ELISA Kit 96 T Elabscience 36990 E-EL-H0092 Human FGF7 (Fibroblast Growth Factor 7) ELISA Kit 96 T Elabscience 36990 E-EL-H0093 Human LEPR (Leptin Receptor) ELISA Kit 96 T Elabscience 36990 E-EL-H0094 Human LIF (Leukemia Inhibitory Factor) ELISA Kit 96 T Elabscience 36990 E-EL-H0095 Human TNFSF14 (Tumor Necrosis Factor Ligand Superfamily, Member 96 T Elabscience 36990 14)ELISA Kit E-EL-H0096 Human NGAL (Neutrophil Gelatinase Associated Lipocalin) ELISA Kit 96 T Elabscience 36990 E-EL-H0097 Human MCSF (Macrophage Colony Stimulating Factor 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0098 Human Pro-MMP-1 (pro-Matrix Metalloproteinase 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0099 Human IL-2 (Interleukin 2) ELISA Kit 96 T Elabscience 36990 E-EL-H0100 Human IL-3 (Interleukin 3) ELISA Kit 96 T Elabscience 36990 E-EL-H0101 Human IL-4 (Interleukin 4) ELISA Kit 96 T Elabscience 36990 E-EL-H0102 Human IL-6 (Interleukin 6) ELISA Kit 96 T Elabscience 36990 E-EL-H0103 Human IL-10 (Interleukin 10) ELISA Kit 96 T Elabscience 36990 E-EL-H0104 Human IL-13(Interleukin 13)ELISA Kit 96 T Elabscience 36990 E-EL-H0105 Human IL-17 (Interleukin 17) ELISA Kit 96 T Elabscience 36990 E-EL-H0106 Human IL-22 (Interleukin 22) ELISA Kit 96 T Elabscience 36990 E-EL-H0107 Human IL-23 (Interleukin 23) ELISA Kit 96 T Elabscience 36990 E-EL-H0108 Human IFN-γ (Interferon Gamma) ELISA Kit 96 T Elabscience 36990 E-EL-H0109 Human TNF-α (Tumor Necrosis Factor Alpha) ELISA Kit 96 T Elabscience 36990 E-EL-H0110 Human TGF-β1 (Transforming Growth Factor Beta 1) ELISA Kit 96 T Elabscience 36990 E-EL-H0111 Human VEGF-A (Vascular Endothelial Cell Growth Factor A ) ELISA Kit 96 T Elabscience 36990 E-EL-H0112 Human EREG (Epiregulin)
Load more

Recommended publications
  • Adherent Intestinal Cells from Atlantic Salmon Show Phagocytic Ability and Express Macrophage-Specific Genes
    fcell-08-580848 October 11, 2020 Time: 9:56 # 1 ORIGINAL RESEARCH published: 15 October 2020 doi: 10.3389/fcell.2020.580848 Adherent Intestinal Cells From Atlantic Salmon Show Phagocytic Ability and Express Macrophage-Specific Genes Youngjin Park1, Qirui Zhang2, Geert F. Wiegertjes3, Jorge M.O. Fernandes1 and Viswanath Kiron1* 1 Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway, 2 Division of Clinical Genetics, Lund University, Lund, Sweden, 3 Aquaculture and Fisheries Group, Wageningen University & Research, Wageningen, Netherlands Our knowledge of the intestinal immune system of fish is rather limited compared to mammals. Very little is known about the immune cells including the phagocytic cells Edited by: Yi Feng, in fish intestine. Hence, employing imaging flow cytometry and RNA sequencing, we The University of Edinburgh, studied adherent cells isolated from healthy Atlantic salmon. Phagocytic activity and United Kingdom selected gene expression of adherent cells from the distal intestine (adherent intestinal Reviewed by: cells, or AIC) were compared with those from head kidney (adherent kidney cells, or Dimitar Borisov Iliev, Institute of Molecular Biology (BAS), AKC). Phagocytic activity of the two cell types was assessed based on the uptake Bulgaria of Escherichia coli BioParticlesTM. AIC showed phagocytic ability but the phagocytes Sherri L. Christian, Memorial University of Newfoundland, were of different morphology compared to AKC. Transcriptomic analysis revealed that Canada AIC expressed genes associated with macrophages, T cells, and endothelial cells. *Correspondence: Heatmap analysis of selected genes indicated that the adherent cells from the two Viswanath Kiron organs had apparently higher expression of macrophage-related genes. We believe [email protected] that the adherent intestinal cells have phagocytic characteristics and high expression Specialty section: of genes commonly associated with macrophages.
    [Show full text]
  • Cytokine Nomenclature
    RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B
    [Show full text]
  • Overlapping, Additive and Counterregulatory Effects of Type II and I Interferons on Myeloid Dendritic Cell Functions
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Serveur académique lausannois Review Article TheScientificWorldJOURNAL (2011) 11, 2071–2090 ISSN 1537-744X; doi:10.1100/2011/873895 Overlapping, Additive and Counterregulatory Effects of Type II and I Interferons on Myeloid Dendritic Cell Functions Loredana Frasca and Roberto Lande Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanita,` 00161 Rome, Italy Received 8 April 2011; Accepted 27 September 2011 Academic Editor: Fulvio D’Acquisto Dendritic cells (DCs) are central player in immunity by bridging the innate and adaptive arms of the immune system (IS). Interferons (IFNs) are one of the most important factors that regulate both innate and adaptive immunity too. Thus, the understanding of how type II and I IFNs modulate the immune-regulatory properties of DCs is a central issue in immunology. In this paper, we will address this point in the light of the most recent literature, also highlighting the controversial data reported in the field. According to the wide literature available, type II as well as type I IFNs appear, at the same time, to collaborate, to induce additive effects or overlapping functions, as well as to counterregulate each one’s effects on DC biology and, in general, the immune response. The knowledge of these effects has important therapeutic implications in the treatment of infec- tious/autoimmune diseases and cancer and indicates strategies for using IFNs as vaccine adju- vants and in DC-based immune therapeutic approaches. KEYWORDS: IFNs, dendritic cell effector functions, immune activation, immune regulation, cross- regulation Correspondence should be addressed to Loredana Frasca, [email protected] Copyright © 2011 L.
    [Show full text]
  • Ligands of Therapeutic Utility for the Liver X Receptors
    molecules Review Ligands of Therapeutic Utility for the Liver X Receptors Rajesh Komati, Dominick Spadoni, Shilong Zheng, Jayalakshmi Sridhar, Kevin E. Riley and Guangdi Wang * Department of Chemistry and RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA; [email protected] (R.K.); [email protected] (D.S.); [email protected] (S.Z.); [email protected] (J.S.); [email protected] (K.E.R.) * Correspondence: [email protected] Academic Editor: Derek J. McPhee Received: 31 October 2016; Accepted: 30 December 2016; Published: 5 January 2017 Abstract: Liver X receptors (LXRs) have been increasingly recognized as a potential therapeutic target to treat pathological conditions ranging from vascular and metabolic diseases, neurological degeneration, to cancers that are driven by lipid metabolism. Amidst intensifying efforts to discover ligands that act through LXRs to achieve the sought-after pharmacological outcomes, several lead compounds are already being tested in clinical trials for a variety of disease interventions. While more potent and selective LXR ligands continue to emerge from screening of small molecule libraries, rational design, and empirical medicinal chemistry approaches, challenges remain in minimizing undesirable effects of LXR activation on lipid metabolism. This review provides a summary of known endogenous, naturally occurring, and synthetic ligands. The review also offers considerations from a molecular modeling perspective with which to design more specific LXRβ ligands based on the interaction energies of ligands and the important amino acid residues in the LXRβ ligand binding domain. Keywords: liver X receptors; LXRα; LXRβ specific ligands; atherosclerosis; diabetes; Alzheimer’s disease; cancer; lipid metabolism; molecular modeling; interaction energy 1.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • New York Chapter American College of Physicians Annual
    New York Chapter American College of Physicians Annual Scientific Meeting Poster Presentations Saturday, October 12, 2019 Westchester Hilton Hotel 699 Westchester Avenue Rye Brook, NY New York Chapter American College of Physicians Annual Scientific Meeting Medical Student Clinical Vignette 1 Medical Student Clinical Vignette Adina Amin Medical Student Jessy Epstein, Miguel Lacayo, Emmanuel Morakinyo Touro College of Osteopathic Medicine A Series of Unfortunate Events - A Rare Presentation of Thoracic Outlet Syndrome Venous thoracic outlet syndrome, formerly known as Paget-Schroetter Syndrome, is a condition characterized by spontaneous deep vein thrombosis of the upper extremity. It is a very rare syndrome resulting from anatomical abnormalities of the thoracic outlet, causing thrombosis of the deep veins draining the upper extremity. This disease is also called “effort thrombosis― because of increased association with vigorous and repetitive upper extremity activities. Symptoms include severe upper extremity pain and swelling after strenuous activity. A 31-year-old female with a history of vascular thoracic outlet syndrome, two prior thrombectomies, and right first rib resection presented with symptoms of loss of blood sensation, dull pain in the area, and sharp pain when coughing/sneezing. When the patient had her first blood clot, physical exam was notable for swelling, venous distension, and skin discoloration. The patient had her first thrombectomy in her right upper extremity a couple weeks after the first clot was discovered. Thrombolysis with TPA was initiated, and percutaneous mechanical thrombectomy with angioplasty of the axillary and subclavian veins was performed. Almost immediately after the thrombectomy, the patient had a rethrombosis which was confirmed by ultrasound.
    [Show full text]
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • Cyclooxygenase-2 Inflammatory Factors, IL-29, IL-8, And
    Hepatitis B Virus Induces a Novel Inflammation Network Involving Three Inflammatory Factors, IL-29, IL-8, and Cyclooxygenase-2 This information is current as of September 27, 2021. Yi Yu, Rui Gong, Yongxin Mu, Yanni Chen, Chengliang Zhu, Zhichen Sun, Mingzhou Chen, Yingle Liu, Ying Zhu and Jianguo Wu J Immunol 2011; 187:4844-4860; Prepublished online 28 September 2011; Downloaded from doi: 10.4049/jimmunol.1100998 http://www.jimmunol.org/content/187/9/4844 http://www.jimmunol.org/ References This article cites 55 articles, 29 of which you can access for free at: http://www.jimmunol.org/content/187/9/4844.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Hepatitis B Virus Induces a Novel Inflammation Network Involving Three Inflammatory Factors, IL-29, IL-8, and Cyclooxygenase-2 Yi Yu,*,†,‡ Rui Gong,*,† Yongxin Mu,*,† Yanni Chen,*,†,‡ Chengliang Zhu,*,† Zhichen Sun,*,† Mingzhou Chen,*,†,‡ Yingle Liu,*,†,‡ Ying Zhu,*,†,‡ and Jianguo Wu*,†,‡ Chronic inflammation induced by hepatitis B virus (HBV) is a major causative factor associated with the development of cirrhosis and hepatocellular carcinoma.
    [Show full text]
  • The Anti-Inflammatory Role of Nuclear Receptors in Dendritic Cells
    The Anti-Inflammatory Role of Nuclear Receptors in Dendritic Cells A thesis submitted for the degree of Ph.D. By Mary Canavan B.Sc. (Hons), March 2012. Based on research carried out at School of Biotechnology, Dublin City University, Dublin 9, Ireland. Under the supervision of Dr. Christine Loscher. Declaration I hereby certify that this material, which I now submit for assessment on the programme of study leading to the award of Doctor of Philosophy is entirely my own work, that I have exercised reasonable care to ensure that the work is original, and does not to the best of my knowledge breach any law of copyright, and has not been taken from the work of others and to the extent that such work has been cited and acknowledged within the text of my work. Signed: ____________________ ID No.:__54351789__ Date: ______________ ACKNOWLEDGEMENTS There are so many people that I would like to thank and definitely not enough space to say exactly how grateful I am to you all. I have been lucky enough to work with an amazing group of people over the past few years. Firstly I would like to thank Christine for all your help, support, enthusiasm and patience – and for telling me not to do anymore of those p50 blots! I have thoroughly enjoyed working with you and learning from you over the last few years. To everyone in the Lab – you are the reason why I have such great memories when I look back at my time in DCU. Whenever I think of failed experiments, tough days and tears, there is always a great memory of you guys that goes along with it.
    [Show full text]
  • Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes
    Published OnlineFirst February 18, 2016; DOI: 10.1158/0008-5472.CAN-15-1548 Cancer Tumor and Stem Cell Biology Research Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor- Infiltrating Lymphocytes Geoffrey J. Markowitz1, Pengyuan Yang1,2,3, Jing Fu3, Gregory A. Michelotti4, Rui Chen1, Jianhua Sui5, Bin Yang2, Wen-Hao Qin3, Zheng Zhang6, Fu-Sheng Wang6, Anna Mae Diehl4, Qi-Jing Li7, Hongyang Wang3, and Xiao-Fan Wang1 Abstract Chronic inflammation in liver tissue is an underlying cause of IL18R1 deletion increased tumor burden. Mechanistically, we hepatocellular carcinoma. High levels of inflammatory cytokine foundthatIL18exertedinflammation-dependent tumor-sup- IL18 in the circulation of patients with hepatocellular carcinoma pressive effects largely by promoting the differentiation, activ- correlates with poor prognosis. However, conflicting results have ity, and survival of tumor-infiltrating T cells. Finally, differences been reported for IL18 in hepatocellular carcinoma development in the expression of IL18 in tumor tissue versus nontumor and progression. In this study, we used tissue specimens from tissueweremorepredictiveofpatientoutcomethanoverall hepatocellular carcinoma patients and clinically relevant mouse tissue expression. Taken together, our findings resolve a long- models of hepatocellular carcinoma to evaluate IL18 expression standing contradiction regarding a tumor-suppressive role for and function. In a mouse model of liver fibrosis that recapitulates IL18 in established hepatocellular carcinoma and provide a a tumor-promoting microenvironment, global deletion of the mechanistic explanation for the complex relationship between IL18 receptor IL18R1 enhanced tumor growth and burden. Sim- its expression pattern and hepatocellular carcinoma prognosis. ilarly, in a carcinogen-induced model of liver tumorigenesis, Cancer Res; 76(8); 1–12.
    [Show full text]
  • HUMAN INTERLEUKIN-29/INTERFERON-LAMBDA 1 Product Number: 11825-1 Lot Number: 5620 Expiration Date: October 2, 2013 Size: 25 Μg
    HUMAN INTERLEUKIN-29/INTERFERON-LAMBDA 1 Product Number: 11825-1 Lot Number: 5620 Expiration Date: October 2, 2013 Size: 25 μg Description: Human Interleukin-29/Interferon-Lambda 1 Source: DNA sequence encoding the signal peptide from human CD33 was fused to the carboxyl terminally polyhistidine-tagged mature human IL-29 (Gly 20 - Thr 200) (Sheppard, P. et al., 2003, Nat. Immunol. 4(1):63 - 68). The chimeric protein was expressed in a mouse myeloma cell line, NS0. Form: Lyophilized Buffer: Phosphate-buffered saline (PBS) containing 50μg of bovine serum albumin (BSA) per 1 μg of cytokine Reconstitution: It is recommended that sterile PBS containing at least 0.1% human serum albumin or bovine serum albumin be added to the vial to prepare a stock solution of no less than 10μg/ml. Endotoxin: < 1 EU/μg Molecular Weight: Based on N-terminal sequencing, the mature recombinant IL-29 starts at Gly 20 and has a calculated molecular mass of 21.4 kDa. As a result of glycosylation, the recombinant monomer migrates as an approximately 26-35kDa protein in SDS-PAGE under reducing conditions. Purity: > 95% Synonyms: Hu IL-29; Hu IFN-λ1 Assays Used to Measure Bioactivity: Human HepG2 cells infected with encephalomyocarditis virus (Sheppard, P. et al., 2003, Nature Immunol. 4:63). The ED50 for this effect is typically 1- 5 ng/mL. Shipping Conditions: Wet Ice Physical State of Product During Shipping: Lyophilized Special Conditions/Comments: After receipt, this product should be kept at -70˚C or below for retention of full activity. Upon reconstitution, this cytokine can be stored under sterile conditions at -20˚C to -70˚C in a manual defrost freezer for three months without detection loss of activity.
    [Show full text]
  • Role of Cornification and Triglyceride Synthesis Genes
    Gillespie et al. BMC Genomics 2013, 14:169 http://www.biomedcentral.com/1471-2164/14/169 RESEARCH ARTICLE Open Access Transcriptome analysis of pigeon milk production – role of cornification and triglyceride synthesis genes Meagan J Gillespie1,2*, Tamsyn M Crowley1,3, Volker R Haring1, Susanne L Wilson1, Jennifer A Harper1, Jean S Payne1, Diane Green1, Paul Monaghan1, John A Donald2, Kevin R Nicholas3 and Robert J Moore1 Abstract Background: The pigeon crop is specially adapted to produce milk that is fed to newly hatched young. The process of pigeon milk production begins when the germinal cell layer of the crop rapidly proliferates in response to prolactin, which results in a mass of epithelial cells that are sloughed from the crop and regurgitated to the young. We proposed that the evolution of pigeon milk built upon the ability of avian keratinocytes to accumulate intracellular neutral lipids during the cornification of the epidermis. However, this cornification process in the pigeon crop has not been characterised. Results: We identified the epidermal differentiation complex in the draft pigeon genome scaffold and found that, like the chicken, it contained beta-keratin genes. These beta-keratin genes can be classified, based on sequence similarity, into several clusters including feather, scale and claw keratins. The cornified cells of the pigeon crop express several cornification-associated genes including cornulin, S100-A9 and A16-like, transglutaminase 6-like and the pigeon ‘lactating’ crop-specific annexin cp35. Beta-keratins play an important role in ‘lactating’ crop, with several claw and scale keratins up-regulated. Additionally, transglutaminase 5 and differential splice variants of transglutaminase 4 are up-regulated along with S100-A10.
    [Show full text]